New diabetes clinical trial: Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Open Wounds
Published on: June 26, 2025 at 11:00PM
Conditions: Diabetic Foot Ulcer; Chronic Wounds; Cellular, Acellular, Matrix-like Product (CAMP); Cellular and/or Tissue Product (CTP); Dehydrated Complete Human Placental Membrane (dCHPM)
Interventions: Other: NeoThelium FT
Sponsors: NuScience Medical Biologics, LLC; SygNola, LLC
Not yet recruiting
https://ift.tt/h9gtM0S
Conditions: Diabetic Foot Ulcer; Chronic Wounds; Cellular, Acellular, Matrix-like Product (CAMP); Cellular and/or Tissue Product (CTP); Dehydrated Complete Human Placental Membrane (dCHPM)
Interventions: Other: NeoThelium FT
Sponsors: NuScience Medical Biologics, LLC; SygNola, LLC
Not yet recruiting
https://ift.tt/h9gtM0S
Comments
Post a Comment